Prakiraan wutah bathi kanggo taun ngarep Cytori Therapeutics (PSTV)

Plus Therapeutics, Inc. (PSTV) is developing a targeted irradiation system by integrating navigation-guided drugs for brain surgery. The current assessment of the company's EPS growth for next year on the GURU.Markets terminal chart confirms this trajectory, where 40.00 reflects the metric's baseline. Patents for targeted isotope delivery provide a protective moat, while partnerships with oncology centers accelerate the market launch of radioligands.

Cytori Therapeutics (PSTV): Dinamika bathi saben saham sing diarepake ing taun ngarep saka 04.07.2022 nganti 03.08.2026

Rincian metrik komprehensif lan analitis Plus Therapeutics (PSTV)

- rega saham lan konsensus proyeksi valuasi:

Rega saham Plus Therapeutics Inc|PSTV - Target konsensus

- rincian kapitalisasi pasar:

Kapitalisasi pasar Plus Therapeutics|PSTV - Total Nilai Perusahaan

- indikator kapitalisasi buku:

Aset Bersih saben Siji Saham Plus Therapeutics|PSTV - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku plustherapeutics.com|PSTV - Nilai Total Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Utang marang Ekuitas Plus Therapeutics, Inc.|PSTV - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Plus Therapeutics Inc|PSTV - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Plus Therapeutics|PSTV - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan Plus Therapeutics|Indikator likuiditas cepet plustherapeutics.com

- data bathi resik lan rasio valuasi:

PSTV - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Plus Therapeutics, Inc.|PSTV - Nilai perusahaan marang bathi resik|Pangali Forward P/E Plus Therapeutics Inc|PSTV - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Plus Therapeutics|PSTV - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Plus Therapeutics|PSTV - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan plustherapeutics.com|PSTV - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Plus Therapeutics, Inc.

- indikator dodolan lan pendapatan:

PSTV - Total pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Plus Therapeutics Inc|PSTV - Multiplikator P/S|Multiplikator forward rega marang pendapatan Plus Therapeutics

Analisis dhasar perusahaan:PSTV, Plus Therapeutics, Inc.

The development of innovative targeted radiotherapy methods for complex tumors forms the long-term capitalization potential of Plus Therapeutics, Inc. (PSTV). This growth target for next year's net income per share visualizes average expert expectations regarding EPS dynamics amid tight monetary policy. Assessing the percentage change in future earnings allows investors to determine the business model's resilience to multiple compression and evaluate the overall investment attractiveness of the asset.

Analisis pesaing

OLMA (Olema Pharma) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Puma Biotechnology Inc (PBYI)|Prakiraan wutah bathi kanggo taun ngarep GLSI|ZNTL - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MacroGenics MGNX|Dinamika bathi saben saham sing diarepake ing taun ngarep PCSA|EGRX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep